Editorial ArticleDrug Discovery & Development
Anti-AAV antibody testing emerges as key to gene therapy
Advance gene therapy precision by reliably testing pre-existing AAV immunogenicity
View articleAdvance gene therapy precision by reliably testing pre-existing AAV immunogenicity
View articleReady-to-use kit from Gyros Protein Technologies enables the detection of binding antibodies against AAV vectors without the need for serotype-specific assays
View articleGyros Protein Technologies introduces new automated kit to overcome major bottleneck in peptide production
View articleReady-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples
View articleNew services to support peptide purification, custom synthesis of PEC-grade peptides, and development and production of peptide drugs and drug candidates
View article